文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 缺血后处理内源性心肌保护的研究进展
侵权投诉

缺血后处理内源性心肌保护的研究进展

再灌注疗法是临床治疗心肌缺血最有效的措施,但会引起再灌注损伤,调动机体内源性保护机制可以减轻再灌注损伤,保护缺血心肌。缺血预处理(ischemic preconditioning, IPC)和后处理(ischemia postconditioning, I-postC)是有效的内源性缺血心肌保护现象,可以减轻缺血再灌注(is

628

生理学报 Acta Physiologica Sinica, October 25, 2007, 59 (5): 628-634

doc.guandang.net

综 述

缺血后处理内源性心脏保护的研究进展

刘秀华*

中国人民解放军总医院病理生理学研究室,北京100853

摘 要:再灌注疗法是临床治疗心肌缺血最有效的措施,但会引起再灌注损伤,调动机体内源性保护机制可以减轻再灌注损伤,保护缺血心肌。缺血预处理(ischemic preconditioning, IPC)和后处理(ischemic postconditioning, I-postC)是缺血心脏有效的内源性保护现象,可以减轻缺血再灌注(ischemia/reperfusion, I/R)后心肌坏死与心肌功能障碍,减少恶性心律失常的发生。内源性心脏保护的机制主要是通过诱导触发因子释放,经多条细胞内信号转导途径的介导,作用于多种效应器,影响氧自由基产生、钙超载等I/R损伤的关键环节而发挥心肌细胞保护作用。特别是可以在缺血后实施的I-postC具有良好的临床应用前景。本文以I-postC为重点综述内源性心脏保护作用、机制及其临床应用现状。关键词:缺血预处理;缺血后处理;心脏保护;信号转导中图分类号:R363.2

Progress in endogenous cardioprotection induced by ischemic postconditioning

LIU Xiu-Hua*

Department of Pathophysiology, Chinese PLA General Hospital, Beijing 100853, China

Abstract: Restoration of blood flow is the definitivetherapy to salvage myocardium following ischemic injury. Sudden restoration ofblood flow to the ischemic myocardiummay, however, also cause reperfusioninjury. Therefore, to prevent such ischemia/reperfusion(I/R) injury, one strategy could be to evoke endogenousmyocardial protective mechanisms. Ischemic preconditioning (IPC) andpostconditioning (I-postC) are endogenousprotective mechanisms capable of protecting the myocardium from myocardial infarction,stunning, and ventricular arrhythmia induced by I/R injury. The mechanisms involve induction of triggers, activation of signalingpathways, and end-effectors, which attenuate generation of free radicals and calcium overload induced by I/R. The fact that I-postC canbe applied after a prolonged period of ischemia offers a novelapproach to myocardial protection. This article mainly reviews thecardioprotection, mechanisms, and application to clinical cardiology of I-postC.

Key words: ischemic preconditioning; ischemic postconditioning; cardioprotection; signal transduction

缺血性心脏病严重危害人类健康,尽早恢复血流是减轻缺血心肌损伤的关键,但是再灌注疗法受缺血组织血管再通时间的限制,并存在再灌注损伤等问题。因此,减轻再灌注损伤成为医学界亟待解决的重大问题。上世纪80年代,始于心外科的临床研究证实控制再灌注条件可减轻再灌注损伤[1],但其不能从根本上控制再灌注损伤的发生和发展。

随后针对缺血再灌注(ischemia/reperfusion, I/R)损伤机制,采用外源性自由基清除剂、钙拮抗剂和山莨菪碱、牛磺酸等细胞保护剂等能有效防治I/R损伤。但是,药物和细胞保护剂的作用依赖有效的再灌注,因此上述外源性干预措施均具有一定的局限性。

上世纪80年代细胞保护概念的提出,使人们认识到激发与扶持机体内源性抗损伤能力是缺血心脏

[2]

Received 2007-07-02 Accepted 2007-08-16

This work was supported by the National Natural Science Foundation of China (No. 30670822), the Major InternationalCollaborative Study of National Natural Science Foundation of China (No. 30620130111), and the National Basic Research Develop-ment Program of China (No. 2007CB512003).

*

Corresponding author. Tel: +86-10-66939763; Fax: +86-10-66939763; E-mail: xiuhualiu98@yahoo.com.cn

第1页

你可能喜欢

  • 心肌缺血
  • 体外循环
  • 研究进展
  • 细胞凋亡通路
  • 氧自由基
  • 信号通路

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email